Phase 3 study of docosahexaenoic acid–paclitaxel versus dacarbazine in patients with metastatic malignant melanoma (Q35003419)
Jump to navigation
Jump to search
scientific article published on September 20, 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase 3 study of docosahexaenoic acid–paclitaxel versus dacarbazine in patients with metastatic malignant melanoma |
scientific article published on September 20, 2010 |
Statements
1 reference
Phase 3 study of docosahexaenoic acid-paclitaxel versus dacarbazine in patients with metastatic malignant melanoma (English)
1 reference
Phase 3 study of docosahexaenoic acid–paclitaxel versus dacarbazine in patients with metastatic malignant melanoma (English)
1 reference
A. Y. Bedikian
R. C. DeConti
R. Conry
S. Agarwala
N. Papadopoulos
K. B. Kim
20 September 2010
1 reference
1 reference
1 reference
1 reference
22
1 reference
4
1 reference
787-793
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference